Acute management of stroke - I

Ischaemic stroke

Trevor T J Chong, Marco Fedi

Research output: Contribution to journalArticleOtherpeer-review

Abstract

The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the importance of timely diagnosis and treatment in order to minimise long-term consequences. The greatest advance in the management of ischaemic stroke has come in the form of reperfusion strategies, the success of which relies upon appropriate patient selection and the prompt initiation of therapy. The benefits of intravenous thrombolysis up to 4.5 hours are now firmly established, with trials underway to determine whether certain subgroups may benefit from thrombolysis beyond this timeframe. Intra-arterial thrombolysis has been used for decades but data on its efficacy and safety are limited. Novel methods of reperfusion, such as mechanical clot retrieval and stenting, have high recanalisation rates with acceptable safety and should be considered in patients with mid- to large-sized artery occlusion. Multi-modal reperfusion therapies, which use a combination of pharmacological and endovascular techniques, are showing encouraging results.

Original languageEnglish
Pages (from-to)363-365
Number of pages3
JournalAnaesthesia and Intensive Care Medicine
Volume14
Issue number9
DOIs
Publication statusPublished - Sep 2013
Externally publishedYes

Keywords

  • Clot retrieval
  • neuroprotection
  • stroke
  • thrombolysis

Cite this

@article{66312aae427b48c9b68bb54c14de1402,
title = "Acute management of stroke - I: Ischaemic stroke",
abstract = "The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the importance of timely diagnosis and treatment in order to minimise long-term consequences. The greatest advance in the management of ischaemic stroke has come in the form of reperfusion strategies, the success of which relies upon appropriate patient selection and the prompt initiation of therapy. The benefits of intravenous thrombolysis up to 4.5 hours are now firmly established, with trials underway to determine whether certain subgroups may benefit from thrombolysis beyond this timeframe. Intra-arterial thrombolysis has been used for decades but data on its efficacy and safety are limited. Novel methods of reperfusion, such as mechanical clot retrieval and stenting, have high recanalisation rates with acceptable safety and should be considered in patients with mid- to large-sized artery occlusion. Multi-modal reperfusion therapies, which use a combination of pharmacological and endovascular techniques, are showing encouraging results.",
keywords = "Clot retrieval, neuroprotection, stroke, thrombolysis",
author = "Chong, {Trevor T J} and Marco Fedi",
year = "2013",
month = "9",
doi = "10.1016/j.mpaic.2013.06.002",
language = "English",
volume = "14",
pages = "363--365",
journal = "Anaesthesia and Intensive Care Medicine",
issn = "1472-0299",
publisher = "Elsevier",
number = "9",

}

Acute management of stroke - I : Ischaemic stroke. / Chong, Trevor T J; Fedi, Marco.

In: Anaesthesia and Intensive Care Medicine, Vol. 14, No. 9, 09.2013, p. 363-365.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Acute management of stroke - I

T2 - Ischaemic stroke

AU - Chong, Trevor T J

AU - Fedi, Marco

PY - 2013/9

Y1 - 2013/9

N2 - The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the importance of timely diagnosis and treatment in order to minimise long-term consequences. The greatest advance in the management of ischaemic stroke has come in the form of reperfusion strategies, the success of which relies upon appropriate patient selection and the prompt initiation of therapy. The benefits of intravenous thrombolysis up to 4.5 hours are now firmly established, with trials underway to determine whether certain subgroups may benefit from thrombolysis beyond this timeframe. Intra-arterial thrombolysis has been used for decades but data on its efficacy and safety are limited. Novel methods of reperfusion, such as mechanical clot retrieval and stenting, have high recanalisation rates with acceptable safety and should be considered in patients with mid- to large-sized artery occlusion. Multi-modal reperfusion therapies, which use a combination of pharmacological and endovascular techniques, are showing encouraging results.

AB - The adage that 'Time is Brain' remains a cornerstone of acute stroke treatment, and reflects the importance of timely diagnosis and treatment in order to minimise long-term consequences. The greatest advance in the management of ischaemic stroke has come in the form of reperfusion strategies, the success of which relies upon appropriate patient selection and the prompt initiation of therapy. The benefits of intravenous thrombolysis up to 4.5 hours are now firmly established, with trials underway to determine whether certain subgroups may benefit from thrombolysis beyond this timeframe. Intra-arterial thrombolysis has been used for decades but data on its efficacy and safety are limited. Novel methods of reperfusion, such as mechanical clot retrieval and stenting, have high recanalisation rates with acceptable safety and should be considered in patients with mid- to large-sized artery occlusion. Multi-modal reperfusion therapies, which use a combination of pharmacological and endovascular techniques, are showing encouraging results.

KW - Clot retrieval

KW - neuroprotection

KW - stroke

KW - thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=84883526135&partnerID=8YFLogxK

U2 - 10.1016/j.mpaic.2013.06.002

DO - 10.1016/j.mpaic.2013.06.002

M3 - Article

VL - 14

SP - 363

EP - 365

JO - Anaesthesia and Intensive Care Medicine

JF - Anaesthesia and Intensive Care Medicine

SN - 1472-0299

IS - 9

ER -